Venus Remedies quarterly results and financials

Venus Remedies (VENUSREM)₹1,448−4.14%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Venus Remedies reported sales of ₹220 Cr, up 13.3% from Sep 2025, and net profit of ₹25.89 Cr, up 30.0% year on year. For the year to Mar 2026, sales were ₹769 Cr and net profit ₹103 Cr.

Sales (Sep 2026): ₹220 Cr
Net profit (Sep 2026): ₹25.89 Cr
Sales (FY Mar 2026): ₹769 Cr
Net profit (FY Mar 2026): ₹103 Cr
EPS (Sep 2026): ₹19.24
Borrowings (Mar 2026): ₹12.01 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Venus Remedies quarterly results

₹ crore unless stated; each column is a quarter.

Venus Remedies Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	144	196	109	171	178	196	137	194	181	260	180	220
Expenses	131	176	96.94	163	158	166	122	162	143	196	145	176
Operating Profit	11.97	18.97	10.98	7.98	17.95	28.93	14.96	30.92	37.93	62.92	33.92	41.90
OPM %	8.1%	10.1%	10.1%	4.5%	10.1%	15.1%	11.1%	16.1%	21.1%	24.1%	19.1%	19.1%
Other Income	2.01	3.99	2.01	8.01	12.01	7.01	3.01	2.01	3.01	5.01	3.01	1.01
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	6.97	5.98	5.98	5.97	4.98	4.98	5.98	5.98	6.97	6.97	6.97	9.96
Profit before tax	7.97	16.94	6.98	8.97	24.92	30.89	12.95	25.92	32.88	61.80	29.92	32.92
Tax %	12.0%	40.0%	82.0%	61.0%	21.0%	32.0%	24.0%	24.0%	24.0%	23.0%	24.0%	23.0%
Exceptional items	0.00	0.00	0.00	0.00	6.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	6.98	10.97	0.99	3.99	19.92	20.91	9.96	19.92	25.91	47.80	22.93	25.89
EPS (Rs)	5.14	7.88	0.92	2.64	14.69	15.74	7.20	15.10	19.18	35.61	17.22	19.24

Venus Remedies profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Venus Remedies Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	408	401	373	323	336	546	599	554	598	648	769	840
Expenses	326	349	333	289	295	490	535	492	537	577	619	660
Operating Profit	80.80	50.92	38.92	32.91	40.90	53.90	61.85	59.88	59.91	68.83	147	177
OPM %	20.1%	13.1%	11.1%	10.1%	12.1%	10.1%	10.0%	11.0%	10.1%	11.1%	19.1%	21.0%
Other Income	2.01	2.01	1.99	−2.99	−3.99	43.01	8.01	10.01	11.99	26.01	13.01	12.04
Interest	38.10	34.07	35.06	25.05	13.04	13.03	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	41.83	39.83	33.89	33.85	31.86	34.84	33.85	31.89	25.90	22.91	25.88	30.87
Profit before tax	3.99	−21.94	−27.92	−29.91	−7.98	48.85	35.90	37.89	44.84	71.75	134	158
Tax %	52.0%	−21.0%	11.0%	−4.0%	24.0%	−27.0%	−12.0%	30.0%	36.0%	37.0%	23.0%	—
Exceptional items	0.00	0.00	0.00	−9.04	−7.02	23.10	0.00	0.00	0.00	15.05	7.03	0.00
Net Profit	1.99	−16.94	−30.89	−28.90	−9.96	61.80	40.84	26.91	27.91	44.82	103	123
EPS (Rs)	1.50	−13.87	−24.95	−23.22	−8.13	50.15	30.55	19.95	21.36	33.97	77.05	91.25
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	13.1%	—

Venus Remedies balance sheet

₹ crore, at each year end.

Venus Remedies Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	11.03	11.01	12.02	12.02	12.01	12.02	12.01	13.03	13.02	13.02	13.02	13.03
Reserves	445	426	376	350	320	311	388	427	447	474	548	649
Borrowings	321	335	312	308	298	220	51.05	43.05	42.08	41.09	2.01	12.01
Other Liabilities	64.17	70.34	65.20	82.31	102	99.71	104	97.46	98.47	98.47	153	179
Total Liabilities	841	844	765	751	734	644	556	580	602	627	717	854
Fixed Assets	444	453	406	389	364	289	262	241	216	219	229	232
CWIP	77.89	79.82	65.88	64.91	64.84	24.94	24.94	24.94	25.96	20.97	25.97	50.93
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.98	18.98	83.87	238
Other Assets	319	310	293	297	304	330	269	314	339	368	376	333
Inventories	142	142	141	137	142	141	119	126	120	122	99.71	129
Trade receivables	62.90	61.95	46.93	46.92	37.95	30.96	31.95	38.96	76.95	79.87	112	103
Cash & equivalents	4.01	7.01	3.99	4.01	3.01	2.01	31.02	50.01	54.01	67.97	80.02	30.01
Total Assets	841	844	765	751	734	644	556	580	602	627	717	854

Venus Remedies cash flow

₹ crore, for each year.

Venus Remedies Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	68.26	47.18	59.17	31.13	45.16	78.32	132	41.17	37.12	37.14	86.34	157
Cash from investing activity	−67.17	3.01	−18.03	8.02	−11.02	−5.01	57.12	−17.04	−58.15	−8.02	−77.24	−185
Cash from financing activity	−1.01	−46.15	−44.13	−39.10	−35.06	−73.23	−163	−9.03	−1.01	−1.01	−1.01	−3.01
Net cash flow	−0.99	3.01	−4.01	0.00	−0.99	0.00	26.99	13.99	−22.01	28.03	8.99	−31.99
Capex	0.00	0.00	23.02	13.02	10.01	8.01	0.00	0.00	8.01	14.02	18.02	38.02
Free cash flow	58.78	45.82	40.89	18.93	34.91	69.76	132	40.88	28.92	23.92	68.75	118
CFO / OP %	76.0%	58.0%	116.0%	79.0%	139.0%	190.0%	245.0%	66.0%	61.0%	89.0%	148.0%	129.0%

Venus Remedies ratios

Working-capital days and returns, by year.

Venus Remedies Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	51	55	43	46	43	33	21	24	51	49	64	49
Inventory days	194	219	226	246	286	296	129	118	132	125	97	122
Days payable	41	39	49	53	73	78	77	48	57	56	90	108
Cash conversion cycle	205	237	222	241	258	253	75	96	128	121	73	65
Working capital days	54	69	54	25	−1	73	71	82	109	118	86	62
ROCE %	6.0%	5.0%	2.0%	1.0%	1.0%	2.0%	8.0%	8.0%	8.0%	9.0%	11.0%	21.0%

Venus Remedies: frequently asked questions

What are the latest quarterly results of Venus Remedies?

For the Sep 2026 quarter, Venus Remedies reported sales of ₹220 Cr, up 13.3% year on year and net profit of ₹25.89 Cr, up 30.0% year on year. The operating margin was 19.1%.

What is the annual revenue of Venus Remedies?

Venus Remedies' sales for the year to Mar 2026 were ₹769 Cr; over the last twelve months they were ₹840 Cr.

What is the net profit of Venus Remedies?

Net profit for the year to Mar 2026 was ₹103 Cr, and ₹123 Cr over the last twelve months. Earnings per share over the same trailing period were ₹91.25.

How much debt does Venus Remedies have?

Venus Remedies reported borrowings of ₹12.01 Cr at Mar 2026, against cash and equivalents of ₹30.01 Cr.

What is the free cash flow of Venus Remedies?

Cash from operations was ₹157 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹118 Cr.

Loading…